NetraMark Holdings Inc C.AIAI

Alternate Symbol(s): AINMF

Healthcare Medical Devices

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.

CSE:AIAI - Post by User

NetraMark Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by waves1on Nov 09, 2021 3:00pm

109 Views

Post# 34106184

MEND on PurposeInvest's fund + CSO podcast & ALS research

Few notable links on Nurosene Health Inc. ( $MEND $MEND.c ):

$MEND has the most portfolio weight in Bruce Campbell's @PurposeInvest small-cap fund.

https://twitter.com/AllStreetsWolf/status/1458138629339959298?s=20

CSO Dr. Geraci was featured on the I am a Mortal podcast regarding Nurosene and NetraMark, as well as how AI will shape the future of healthcare

https://open.spotify.com/show/1aX9zM67UVN5tv19v7GsDw?si=nVy0bg4zS0u2ZosF6R6NTw

Plus, Dr. Geraci is presenting his research on ALS at the EndALS Pitch Day hosted by a data science subsidiary of Google today. He was requested to help prepare genetic data to discover a set of new drug targets and repurpose candidates for ALS patients.

https://finance.yahoo.com/news/nurosenes-chief-scientific-officer-dr-140000074.html

$MEND is positioned at the leading edge of critical research and innovations, striving to disrupt traditional mental wellness treatments. As the global market size for mobile health applications (mHealth) is expected to reach USD $310 billion by 2027, $MEND has the ability to capitalize off its upcoming growth and is likely to do so.

<< Previous

Bullboard Posts

Next >>

Odd Burger to add 40 locations in Florida